Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Schizophrenia Research. Cognition|January 10, 2022
Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophreniaAditi Kadakia, Qi Fan, Jason Shepherd, et al.
Psychiatry Journal|September 16, 2020
Assessment of Real-Life Outcomes in Schizophrenia Patients according to ComplianceZaina P Qureshi, Rezaul Khandker, Jason Shepherd, et al.
The Primary Care Companion for CNS Disorders|December 28, 2020
A Real-World Assessment of Outcomes in Schizophrenia Patients According to Treatment ResponseRezaul Khandker, Zaina P Qureshi, Jason Shepherd, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2018
Interneuron Simplification and Loss of Structural Plasticity As Markers of Aging-Related Functional DeclineRonen Eavri, Jason Shepherd, Christina A Welsh, et al.
Current Medical Research and Opinion|November 23, 2021
Point-in-time survey of healthcare resource utilization, employment, quality of life and caregiver status by disease severity in patients with schizophrenia in the USAditi Kadakia, Qi Fan, Jason Shepherd, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 30, 2017
Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 InhibitorsPallavi B Rane, Jeetvan Patel, David J Harrison, et al.
Optics Express|February 25, 2022
Scan-less machine-learning-enabled incoherent microscopy for minimally-invasive deep-brain imagingRuipeng Guo, Soren Nelson, Matthew Regier, et al.
Neuropsychiatric Disease and Treatment|May 25, 2022
Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated OutcomesRezaul Khandker, Jason Shepherd, Farid Chekani, et al.
Molecular Aspects of Medicine|May 21, 2025
Virus-like particles of retroviral origin in protein aggregation and neurodegenerative diseasesSerena Carra, Balazs Fabian, Hamed Taghavi, et al.
Current Medical Research and Opinion|October 6, 2018
Real-world treatment patterns of PCSK9 inhibitors among patients with dyslipidemia in Germany, Spain, and the United KingdomMing-Hui Tai, Jason Shepherd, Hollie Bailey, et al.
Pageof 3